Asthma Clinical Trial
Official title:
Family Learning on Asthma Topics
1. Hypothesis: The Family Learning on Asthma Topics (F.L.O.A.T) in the form of a a group
teaching environment for family education stemming from standardized education materials
on asthma, created and taught by nationally certified asthma educators will promote
optimal asthma knowledge, management and quality of life among the individuals with
asthma and their caregivers.
2. Aim 1: To determine if the availability of educational services outside of regular
clinic hours or admission status could improve asthma outcomes and decrease unnecessary
medical utilization.
3. Aim 2: By providing small-group learning environments for families, the investigators
aim to encourage families to learn from each other's experiences and to decrease stigma
around the disease.
I. Hypotheses and Specific Aims:
1. Hypothesis: The Family Learning on Asthma Topics (F.L.O.A.T) in the form of a a group
teaching environment for family education stemming from standardized education materials
on asthma, created and taught by nationally certified asthma educators will promote
optimal asthma knowledge, management and quality of life among the individuals with
asthma and their caregivers.
2. Aim 1: To determine if the availability of educational services outside of regular
clinic hours or admission status could improve asthma outcomes and decrease unnecessary
medical utilization.
3. Aim 2: By providing small-group learning environments for families, the investigators
aim to encourage families to learn from each other's experiences and to decrease stigma
around the disease.
II. Background and Significance:
Despite recent improvements in treatment and the ongoing research in better understanding of
the disease, emergency room visits and hospitalization rates for asthma remain high. The
Centers for Disease Control and Prevention surveillance data reports that at a national
level, health care use for emergency department services for asthma was 1.6 million in 2013,
and that of 439,435 hospital admissions for asthma 136,669 or 31% are for children below the
age of 18 years of age. The annual cost of asthma on the U.S. economy equates to more than
$80 billion in medical expenses, including days missed from school, work and even death.
Nurmagambetov, et.al. in their study state that the "combined costs of medical care,
mortality, and absenteeism render the total cost of asthma a substantial and serious economic
burden on society. These findings highlight the critical need to support and further
strengthen asthma control strategies through increased provision of guideline-based care,
improvements in self-management, and reduction of environmental asthma triggers to reduce ER
visits, hospitalizations, absenteeism, and mortality".
Bäuerle et al. used a prospective single-center controlled trial to show that by providing
motivating and patient-oriented didactics on asthma, there is a statistically significant
increase in asthma health outcomes and that asthma control can be improved by education
measures. Although it is a key component of all international asthma guidelines, education in
self-management is still insufficiently available in primary care settings. In the ambulatory
setting, there are some families that require more extensive education and time is limited in
a usual care appointment to address all their specific asthma needs.
Providing patient education by an experienced asthma educator is an important step in
supporting patients and families as they are diagnosed with asthma and as they adapt to life
with a chronic condition. Educating families about the nature of the disease, triggers,
identification of early signs and symptoms, principles of treatment, and asthma management
can reduce children's use of acute care services. According to Srof et al., asthma management
education programs should be connected to the chronic illness management within the fabric of
the family system. The paradigm of group education supports engagement, promoting
communication among all participants including facilitator to enhance a social construct for
validating personal experiences, empowering caregivers, and solving asthma management
problems.
III. Preliminary Studies/Progress Report: none
IV. Research Methods
A. Outcome Measure(s):
Decrease emergency room visits, hospitalizations, and systemic steroid use for each child 12
months after completing the three, group classroom educational sessions.
1. Description of Population to be Enrolled:
The investigators will enroll legal guardians and or primary caregiver (18 years and
older) of children 4-17 years of age along with those children/adolescents who have a
diagnosis of asthma, and have documented poor control as evidenced by requiring two or
more systemic steroids, one or more hospitalizations and/or two or more ED visits due to
asthma in the 12 months prior to the asthma clinic or hospital visit. Patients and
caregivers will be English or Spanish speaking.
2. Study Design and Research Methods:
Patients and caregivers will be recruited from the Pulmonary outpatient clinic and
inpatient services at Children's Hospital Colorado. Patients will also be referred to
the Family Learning on Asthma Topic (F.L.O.A.T) program by health care providers
participating in these clinics/inpatient service. Children will be: 1) 4-17 years age,
2) have poor evidence of asthma control based on > 2 systemic steroid courses; > 2
Emergency Room visits; and >1 hospitalization for asthma exacerbation in the preceding
12 months. The investigators anticipate to enroll 75 patients and enrollment to begin in
the Spring 2019 through the Spring 2020.
Family Learning on Asthma Topics classes will aim to emphasize, encourage, and support
teaching methods that include standardized instructions. There will be three topics
lasting approximately 45 minutes: General Asthma Knowledge; Asthma Triggers,
Medications, and Self-Management. These topics were chosen based on the EPR-3 guideline
recommendations to ensure the continuity of messaging. Each class size will be
approximately 8 persons and will be taught by a Certified Asthma Educator (AE-C) and
will be held in the Family Learning Center at the Children's Hospital Colorado. Classes
will be taught in both English and Spanish. An in person Spanish asthma educator will be
available to help teach the classes.
The materials used for each class were created by the CHCO Health Literacy Team in
collaboration with Asthma Educator Certified members of the Breathing Institute to
ensure that evidence-based information will be communicated effectively to patients and
families. Instead of a lecture style course, each class will facilitate interactive
learning for patients and families to help them prepare for real life problem-solving
and to promote self-awareness regarding medication use.
Patient and families enrolled will be notified of the class schedule and receive
reminders 1 week and the day before each of their classes either through email, phone
call and or text messaging.
There will be a general asthma knowledge questionnaire consisting of 12 questions and
the standardized Asthma Control Test (ACT) that consists of 7 standardized questions,
one for children 4 - 11 years of age and one for children 12 years and older, that
participants will fill out at the start of their first class. After each class, there
will be 4 questions to be answered regarding their understanding of that class. Handouts
and visuals will be available in English and Spanish pertaining to information about
that class. Other class materials will include a folder to keep their handouts in and
paper and pencils for note taking. Peak flow meters and their Asthma Action Plans will
also be provided. At the completion of the class series there will be a satisfaction
survey, participants will fill out anonymously.
Twelve months following the completion of the class series, the investigators will be
conducting a chart review gathering data on frequency of emergency room visits,
hospitalizations and systemic steroid use for asthma exacerbations along with any
routine follow up visits for asthma.
3. Description, Risks and Justification of Procedures and Data Collection Tools:
Data collected will be through pre and post class questionnaires, Asthma Control Test (ACT),
validated Inhaler Technique Assessment Tool (iDAT), and demographic information filled out by
the families and noted in their EMR (EPIC). Information about participant's asthma care
utilization and systemic steroid use will be obtained through EMR/EPIC chart review, 12
months prior to enrollment and 12 months post last completed class. All information will be
entered in to a secure REDCap data base and paper copies will be kept in the locked research
cabinet of study personnel.
E. Potential Scientific Problems: The investigators do not anticipate any scientific problems
F. Data Analysis Plan:
Inclusion requirements will be defined through the electronic medical record based on
inclusion requirements by either the outpatient pulmonary team or inpatient asthma education
team.
After enrollment the following information will be placed into RedCap (HIPPA compliant
database) from the EMR: Childs name, DOB, Race, Ethnicity, Cell phone number, Email, Zip
Code, Sex, Preferred language (caregiver), Pulmonary or Allergy specialist seen within the
previous year, Payer, Hospital visits (ED and hospital visits) 12 months prior to consent.
Right after enrollment a pre-knowledge base survey of 12 questions and asthma control survey
of 7 questions will be sent via RedCap to caregivers defined phone and email. The data will
be collected electronically and stored in RedCap.
Throughout the 4-month study period, every week an administrative support person will pull
the child's name, caregivers name, designated contact phone number, and email from RedCap
databased to send a text, email, and phone call reminders of upcoming classes and asking the
caregiver to reply electronically if they are planning on attending. The administrative
assistant will review the reply's and notify the educators of the number of class attendees
and their names.
Upon completing each of the three classes the instructor will ask for the administrative
assistant to send a post knowledge bases survey of 4 questions out of RedCap to the primary
caregiver. The electronic responses will be electronically entered into RedCap.
Upon completion of the 3 classes and/or 4months the administrative assistant will send a
post-knowledge survey consisting of 12 questions, an asthma control test survey of 7
questions, and a satisfaction survey to the primary caregiver. The electronic responses will
be entered into RedCap.
Each quarter the overview of pre-knowledge base survey results, post-knowledge survey results
and satisfaction survey will be reviewed by the team members to evaluate if any changes need
to be made to the education curriculum.
Child specific data will be reviewed 12 months after completion of the classes and/or study.
G. Summarize Knowledge to be Gained:
By conducting this group focused asthma education series for high risk asthmatics and their
care givers, the investigators anticipate improved knowledge along with retention of
knowledge gained through these classes thereby reducing exacerbations, and need for acute
care interventions. Group centered learning will enhance opportunities to learn from others
who may have similar experiences and will generate discussion and new skills and ideas.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|